Guidances

Advocates also say the Biden administration could make significant headway by simply reversing the executive actions, guidances and memos put out by the Trump administration over the past four years.

The updated recommendations in these guidances are based on data and analysis that the FDA believes are applicable to circumstances outside of (and after) the COVID-19 pandemic and reflect the agency’s current thinking on this issue.

But the agency said it would soon publish two guidances, recommendations for drugmakers, on the issue.

There are many, many agency guidances, published by dozens of federal agencies, on hundreds or even thousands of different topics.

Despite display rules and guidances, accidents have continued to happen.